Dr. Christopher A. Klebanoff, MD, is a medical oncologist and translational researcher specializing in early drug development for breast cancer. He is a member of the Center for Cell Engineering and the Parker Institute for Cancer Immunotherapy at Memorial Sloan Kettering Cancer Center, where he combines laboratory research with clinical trial work to advance novel cancer therapies. His scientific expertise spans cellular therapy and genetic engineering, immune-stimulating antibodies and cytokines, and cancer vaccines. Driven by a deep personal understanding of cancer's impact, having experienced its effects within his own family, Dr. Klebanoff brings both scientific rigor and genuine empathy to his clinical practice.
Why they are a top doctor
Research papers · PubMed
102
Published, peer-reviewed work, the clearest public measure of expertise in a specialty.
Cited by other doctors
26.1k
How often other doctors and researchers build on their work.
Known for
Immunotherapy and cellular therapy
The distinction that sets them apart from other cellular therapist & early drug development specialists.
Specializes in
Cancer vaccines
A narrow focus means they see far more of these cases than a general oncologist.
Background
Education
Medical school: MD, Emory University School of Medicine
Residency: The Johns Hopkins Hospital
Fellowship: National Cancer Institute · National Institutes of Health
Board certifications: Internal Medicine · Medical Oncology
Awards
Fellows Award for Research Excellence, National Institutes of Health (2013)
Outstanding Postdoctoral Fellow, National Cancer Institute (2011)